DBVT
Price
$11.85
Change
-$1.12 (-8.64%)
Updated
Sep 11 closing price
Capitalization
825.94M
Intraday BUY SELL Signals
KYMR
Price
$114.96
Change
-$2.04 (-1.74%)
Updated
Sep 11 closing price
Capitalization
9.56B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DBVT vs KYMR

DBVT vs KYMR Comparison Chart in %
View a ticker or compare two or three
VS
DBVT vs. KYMR commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and KYMR is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($9.57B) has a higher market cap than DBVT($826M). KYMR YTD gains are higher at: 47.745 vs. DBVT (-38.185). DBVT has higher annual earnings (EBITDA): -166.22M vs. KYMR (-291.04M). KYMR has more cash in the bank: 691M vs. DBVT (175M). DBVT has less debt than KYMR: DBVT (7.7M) vs KYMR (78.6M). KYMR has higher revenues than DBVT: KYMR (105M) vs DBVT (0).
DBVTKYMRDBVT / KYMR
Capitalization826M9.57B9%
EBITDA-166.22M-291.04M57%
Gain YTD-38.18547.745-80%
P/E RatioN/AN/A-
Revenue0105M-
Total Cash175M691M25%
Total Debt7.7M78.6M10%
FUNDAMENTALS RATINGS
DBVT vs KYMR: Fundamental Ratings
DBVT
KYMR
OUTLOOK RATING
1..100
5284
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
10045
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
6335
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
5023

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DBVT's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for KYMR (89) in the null industry. This means that DBVT’s stock grew somewhat faster than KYMR’s over the last 12 months.

KYMR's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for DBVT (100) in the Biotechnology industry. This means that KYMR’s stock grew somewhat faster than DBVT’s over the last 12 months.

KYMR's SMR Rating (95) in the null industry is in the same range as DBVT (99) in the Biotechnology industry. This means that KYMR’s stock grew similarly to DBVT’s over the last 12 months.

KYMR's Price Growth Rating (35) in the null industry is in the same range as DBVT (63) in the Biotechnology industry. This means that KYMR’s stock grew similarly to DBVT’s over the last 12 months.

KYMR's P/E Growth Rating (83) in the null industry is in the same range as DBVT (100) in the Biotechnology industry. This means that KYMR’s stock grew similarly to DBVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DBVTKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (DBVT: $11.85 vs. KYMR: $114.96)
Brand notoriety: DBVT and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 841% vs. KYMR: 72%
Market capitalization -- DBVT: $825.94M vs. KYMR: $9.56B
DBVT [@Biotechnology] is valued at $825.94M. KYMR’s [@Biotechnology] market capitalization is $9.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green while KYMR’s FA Score has 0 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than DBVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • DBVT’s TA Score: 5 bullish, 3 bearish.
  • KYMR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than KYMR.

Price Growth

DBVT (@Biotechnology) experienced а -12.03% price change this week, while KYMR (@Biotechnology) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DBVT
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX53.13N/A
N/A
Rydex Biotechnology C
OGMIX68.11N/A
N/A
Invesco Gold & Special Minerals R6
HNMDX14.99N/A
N/A
Heartland Mid Cap Value Institutional
CLRYX24.28N/A
N/A
Columbia Large Cap Growth Opp Inst3
FNFWX108.37-0.72
-0.66%
American Funds New World 529-F-2

DBVT and

Correlation & Price change

A.I.dvisor tells us that DBVT and GPCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and GPCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
-8.64%
GPCR - DBVT
32%
Poorly correlated
-2.25%
CRDF - DBVT
32%
Poorly correlated
N/A
RXRX - DBVT
31%
Poorly correlated
+1.27%
CGEN - DBVT
31%
Poorly correlated
+0.41%
KYMR - DBVT
30%
Poorly correlated
-1.74%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.74%
GPCR - KYMR
62%
Loosely correlated
-2.25%
NRIX - KYMR
57%
Loosely correlated
-2.75%
WVE - KYMR
50%
Loosely correlated
-1.71%
OCUL - KYMR
45%
Loosely correlated
-1.22%
REPL - KYMR
44%
Loosely correlated
-2.42%
More